Serveur d'exploration sur la rapamycine et les champignons - Exploration (Accueil)

Index « Mesh.i » - entrée « Liver Transplantation »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Liver Neoplasms, Experimental < Liver Transplantation < Living Donors  Facettes :

List of bibliographic references indexed by Liver Transplantation

Number of relevant bibliographic references: 38.
[0-20] [0 - 20][0 - 38][20-37][20-40]
Ident.Authors (with country if any)Title
000262 (2019) Karen E. Ocwieja [États-Unis] ; Sara O. Vargas [États-Unis] ; Scott A. Elisofon [États-Unis] ; David S. Shulman [États-Unis] ; Christine K. Lee [États-Unis] ; Rima Fawaz [États-Unis] ; Natalie Collins [États-Unis] ; Khashayar Vakili [États-Unis] ; Tanvi S. Sharma [États-Unis]Pediatric post-transplant hepatic kaposi sarcoma due to donor-derived human herpesvirus 8.
000324 (2019) Daniel Shepshelovich [Israël] ; Noam Tau [Israël] ; Hefziba Green [Israël] ; Benaya Rozen-Zvi [Israël] ; Assaf Issaschar [Israël] ; Marco Falcone [Italie] ; Julien Coussement [Belgique] ; Oren Zusman [Israël] ; Oriol Manuel [Suisse] ; Eytan Mor [Israël] ; Julian Torre-Cisneros [Espagne] ; Dafna Yahav [Israël]Immunosuppression reduction in liver and kidney transplant recipients with suspected bacterial infection: A multinational survey.
000350 (2019) Tong-Wei Guan [République populaire de Chine] ; Yi-Jin Lin [République populaire de Chine] ; Meng-Ying Ou [République populaire de Chine] ; Ke-Bao Chen [République populaire de Chine]Efficacy and safety of everolimus treatment on liver transplant recipients: A meta-analysis.
000657 (2018) G. Schmalz [Allemagne] ; L. Berisha ; H. Wendorff ; F. Widmer ; A. Marcinkowski ; H. Teschler ; U. Sommerwerck ; R. Haak ; O. Kollmar ; D. ZiebolzAssociation of time under immunosuppression and different immunosuppressive medication on periodontal parameters and selected bacteria of patients after solid organ transplantation.
000859 (2017) A. Frey [Allemagne] ; E-M Ecker [Allemagne] ; K. Piras-Straub [Allemagne] ; A. Walker [Allemagne] ; T G Hofmann [Allemagne] ; J. Timm [Allemagne] ; B B Singer [Allemagne] ; G. Gerken [Allemagne] ; K. Herzer [Allemagne]Effects of the Mammalian Target of Rapamycin Inhibitor Everolimus on Hepatitis C Virus Replication In Vitro and In Vivo.
000A03 (2016) Yun-Wei Guo [République populaire de Chine] ; Hua-Ying Gu [République populaire de Chine] ; Kodjo-Kunale Abassa [République populaire de Chine] ; Xian-Yi Lin [République populaire de Chine] ; Xiu-Qing Wei [République populaire de Chine]Successful treatment of ileal ulcers caused by immunosuppressants in two organ transplant recipients.
000A04 (2016) Niloufar Safinia [Royaume-Uni] ; Trishan Vaikunthanathan [Royaume-Uni] ; Henrieta Fraser [Royaume-Uni] ; Sarah Thirkell [Royaume-Uni] ; Katie Lowe [Royaume-Uni] ; Laura Blackmore [Royaume-Uni] ; Gavin Whitehouse [Royaume-Uni] ; Marc Martinez-Llordella [Royaume-Uni] ; Wayel Jassem [Royaume-Uni] ; Alberto Sanchez-Fueyo [Royaume-Uni] ; Robert I. Lechler [Royaume-Uni] ; Giovanna Lombardi [Royaume-Uni]Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation.
000A11 (2016) Chuan Shen [République populaire de Chine] ; Chenghong Peng [République populaire de Chine] ; Baiyong Shen [République populaire de Chine] ; Zhecheng Zhu [République populaire de Chine] ; Ning Xu [République populaire de Chine] ; Tao Li [République populaire de Chine] ; Junjie Xie [République populaire de Chine]Sirolimus and metformin synergistically inhibit hepatocellular carcinoma cell proliferation and improve long-term survival in patients with HCC related to hepatitis B virus induced cirrhosis after liver transplantation.
000A93 (2016) E J Lim [Australie] ; R. Chin [Australie] ; U. Nachbur [Australie] ; J. Silke [Australie] ; Z. Jia [Australie] ; P W Angus [Australie] ; J. Torresi [Australie]Hepatitis C-induced hepatocyte apoptosis following liver transplantation is enhanced by immunosuppressive agents.
000C37 (2015) Faouzi Saliba [France] ; Frederik NevensProgression of liver fibrosis in HCV-positive liver transplant recipients randomized to everolimus with reduced calcineurin inhibitor (CNI) therapy or a standard CNI regimen.
000D05 (2015) Eu Jin Lim [Australie] ; Ruth Chin [Australie] ; Ueli Nachbur [Australie] ; John Silke [Australie] ; Zhiyuan Jia [Australie] ; Peter W. Angus [Australie] ; Joseph Torresi [Australie]Effect of Immunosuppressive Agents on Hepatocyte Apoptosis Post-Liver Transplantation.
000F14 (2014) Eylem Akar Zkan [Turquie] ; B Handan Özdemir ; Ayd Ncan Akdur ; E Ebru Deniz ; Mehmet HaberalBurkitt lymphoma after transplant: an aggressive lymphoproliferative disease.
000F47 (2013) Ivone Malla ; Celeste Pérez ; Yu Cheang ; Marcelo Silva[Human herpesvirus 8 related Kaposi's sarcoma in a pediatric liver transplant recipient: case report].
001057 (2013) Jacqueline G. O'Leary ; Gregory J. Mckenna ; Göran B. Klintmalm ; Gary L. DavisEffect of telaprevir on the pharmacokinetics of sirolimus in liver transplant recipients.
001140 (2012) Audrey Coilly [France] ; Valérie Furlan ; Bruno Roche ; Caroline Barau ; Coralie Noël ; Laurence Bonhomme-Faivre ; Teresa Maria Antonini ; Anne-Marie Roque-Afonso ; Didier Samuel ; Anne-Marie Taburet ; Jean-Charles Duclos-ValléePractical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence.
001159 (2012) Nicholas N. Nissen [États-Unis] ; Burc Barin ; Peter G. StockMalignancy in the HIV-infected patients undergoing liver and kidney transplantation.
001167 (2012) Fabrizio Di Benedetto ; Massimiliano Berretta ; Nicola De Ruvo ; Giuseppe Tarantino ; Giuseppe D'Amico ; Roberto Ballarin ; Rosa Maria Iemmolo ; Giorgio E. GerundaIs advanced hepatocellular carcinoma amenable of cure by liver transplantation with sorafenib as a neoadjuvant approach plus m-TOR inhibitors monotherapy?
001178 (2012) Aaron James Chan [États-Unis] ; John R. LakeImmunosuppression in HCV-positive liver-transplant recipients.
001233 (2011) T. Casanovas [Espagne] ; A. Argudo ; M C Pe A-CalaEffectiveness and safety of everolimus in the treatment of autoimmune hepatitis related to anti-hepatitis C virus therapy after liver transplant: three case reports.
001248 (2011) Sonal Asthana ; Christian Toso ; Glenda Meeberg ; David L. Bigam ; Andrew Mason ; James Shapiro ; Norman M. KnetemanThe impact of sirolimus on hepatitis C recurrence after liver transplantation.
001259 (2011) Simon J F. Harper [Royaume-Uni] ; William Gelson ; Ines G. Harper ; Graeme J M. Alexander ; Paul GibbsSwitching to sirolimus-based immune suppression after liver transplantation is safe and effective: a single-center experience.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Liver Transplantation" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Liver Transplantation" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Liver Transplantation
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020